• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉支架置入术后晚期冠状动脉支架移位

Late coronary stent dislodgement following coronary artery stenting.

作者信息

Aydin E, Ozen Y, Sarikaya S, Arslan O, Kirali K, Alp M

机构信息

Kartal Kosuyolu Training and Research Hospital, Istanbul, Turkey.

出版信息

Cardiovasc J Afr. 2015 Feb 23;26(1):e4-7. doi: 10.5830/CVJA-2014-073.

DOI:10.5830/CVJA-2014-073
PMID:25784497
Abstract

Recently, coronary artery stenting has been successful when used as an intervention for percutaneous coronary artery disease. However, the procedure may frequently produce complications. Although rare, stent dislodgement is one such complication, which may result in serious problems including coronary artery dissection, myocardial infarction, peripheral embolisation and death. Stent dislodgement is known to be an early complication of the coronary artery stenting procedure. In this case report, we present a 53-year-old male with late coronary stent dislodgement. To the best of our knowledge, no such case has been addressed in the literature to date.

摘要

最近,冠状动脉支架置入术作为经皮冠状动脉疾病的一种干预手段已取得成功。然而,该手术可能经常产生并发症。支架移位虽罕见,但也是其中一种并发症,可能导致严重问题,包括冠状动脉夹层、心肌梗死、外周栓塞和死亡。支架移位是冠状动脉支架置入术的一种早期并发症。在本病例报告中,我们介绍了一名53岁发生晚期冠状动脉支架移位的男性患者。据我们所知,迄今为止文献中尚未有此类病例的报道。

相似文献

1
Late coronary stent dislodgement following coronary artery stenting.冠状动脉支架置入术后晚期冠状动脉支架移位
Cardiovasc J Afr. 2015 Feb 23;26(1):e4-7. doi: 10.5830/CVJA-2014-073.
2
Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).晚期和极晚期药物洗脱支架血栓形成的相关因素和结果:DESERT(国际药物洗脱支架血栓形成事件注册研究)的结果。
JACC Cardiovasc Interv. 2014 Oct;7(10):1093-102. doi: 10.1016/j.jcin.2014.04.017. Epub 2014 Sep 17.
3
Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.经皮冠状动脉分叉病变挤压与 Culotte 支架置入术的临床结果:北欧支架技术研究 36 个月随访结果。
JACC Cardiovasc Interv. 2013 Nov;6(11):1160-5. doi: 10.1016/j.jcin.2013.06.009.
4
Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.比较接受西罗莫司洗脱支架治疗后伴有和不伴有无保护左主干冠状动脉疾病患者的 5 年结局:来自 j-Cypher 注册研究的结果。
JACC Cardiovasc Interv. 2013 Jul;6(7):654-63. doi: 10.1016/j.jcin.2013.03.015.
5
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).首例人体生物可吸收聚合物涂层依维莫司洗脱支架的评估:DESOLVE I 试验(载有依维莫司和生物可吸收聚合物的 DES 治疗原发性冠状动脉病变患者)的影像学和临床结果。
JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013. Epub 2013 Sep 18.
6
Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.依维莫司洗脱 Xience v/Promus 支架与佐他莫司洗脱 Resolute 支架在糖尿病患者中的应用比较。
JACC Cardiovasc Interv. 2014 May;7(5):471-81. doi: 10.1016/j.jcin.2013.12.201.
7
Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem.使用生物可吸收支架治疗极晚期金属支架贴壁不良和支架内再狭窄:解决老问题的新选择。
EuroIntervention. 2015 Aug;11(4):e1. doi: 10.4244/EIJV11I4A88.
8
Stent dislodgement during withdrawal attempt into the guiding-catheter: A step-by-step retrieval technique.支架在试图撤回导管时脱落:一种逐步取回技术。
Catheter Cardiovasc Interv. 2024 Jul;104(1):21-22. doi: 10.1002/ccd.31081. Epub 2024 May 25.
9
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).在冠状动脉疾病中,依维莫司洗脱支架与紫杉醇洗脱支架的荟萃分析:SPIRIT 临床试验计划的最终 3 年结果(在治疗新发病变的患者中,使用依维莫司洗脱冠状动脉支架系统治疗的西里斯 V 依维莫司洗脱冠状动脉支架系统的临床评估)。
JACC Cardiovasc Interv. 2013 Sep;6(9):914-22. doi: 10.1016/j.jcin.2013.05.005.
10
Approaches for dislodged stent retrieval during transradial percutaneous coronary interventions.经桡动脉入路行冠状动脉介入治疗时脱载支架的取出方法。
Catheter Cardiovasc Interv. 2013 May;81(6):E245-9. doi: 10.1002/ccd.24483. Epub 2012 Nov 12.

引用本文的文献

1
Left main stenting with stent dislodgement and entrapment in the common femoral artery: a successful transcatheter stent retrieval.左主干支架置入术伴支架移位并嵌顿于股总动脉:经导管成功取出支架
Am J Cardiovasc Dis. 2021 Jun 15;11(3):421-428. eCollection 2021.